Elanco
The Research Scientist (R1 level) in the Vaccine Technical Development area leads and advances R&D projects with a specialized focus on innovative fermentation and bioreactor technologies. This role ensures projects progress on schedule and within budget by leveraging extensive scientific expertise in advanced upstream bioprocessing. The position involves project ownership, strategic planning, and fostering a positive, accountable work environment within the Process Development functional group.
Headquarters
Indianapolis, Indiana, United States
Company Size
5001-10000 employees
Founded
1954
As a global leader in animal health, Elanco provides innovative solutions to improve animal health and wellbeing for both farm animals and pets. For more than 70 years, Elanco has empowered veterinarians, farmers, and animal health professionals to transform animal care. Making life better for animals, makes life better.
Elanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?
11 hours ago
Why Elanco (ELAN) Is Down 8.2% After Guiding Higher 2026 Revenue Despite Ongoing Net Losses
2 days ago
Barrow Hanley Mewhinney & Strauss LLC Sells 2,592,747 Shares of Elanco Animal Health Incorporated $ELAN
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Elanco.
Elanco didn’t post a salary, so this is our estimate from similar listings.
Elanco Animal Health stock reaffirmed at Buy by UBS on innovation momentum
1 day ago